Doorgaan naar inhoud

Verloskunde

Behandeling van trombocytopenie

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (opent nieuw venster)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Bron‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Geïndexeerd‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (opent nieuw venster)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (opent nieuw venster)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Bron‎: Blood 2020;136(26):3056-61.

Geïndexeerd‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (opent nieuw venster)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (opent nieuw venster)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Bron‎: Asian J Transfus Sci 2016;10(2):155-8.

Geïndexeerd‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (opent nieuw venster)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (opent nieuw venster)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Bron‎: Blood 2013;121(3):537-45.

Geïndexeerd‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (opent nieuw venster)